Insider trading

Period: 120 months Stock: RNAC Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

106 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

106 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

106 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

106 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
106 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
106 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

106 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
5 Jan 2023
Brunn Carsten President and CEO
Sold, plan not stated 2×
$15.21K 13,473 at 1.13
1.7%
5 Jan 2023
TRABER PETER G Chief Medical Officer
Sold, plan not stated 2×
$3.91K 3,465 at 1.13
0.8%
5 Jan 2023
Kishimoto Takashi Kei Chief Scientific Officer
Sold, plan not stated 2×
$3.83K 3,392 at 1.13
0.9%
5 Jan 2023
Johnston Lloyd P. Chief Operations Officer
Sold, plan not stated 2×
$3.83K 3,392 at 1.13
1.3%
4 Jan 2023
Brunn Carsten President and CEO
Sold, plan not stated 2×
$31.29K 27,597 at 1.13
3.3%
4 Jan 2023
TRABER PETER G Chief Medical Officer
Sold, plan not stated 2×
$9.27K 8,179 at 1.13
1.8%
4 Jan 2023
Kishimoto Takashi Kei Chief Scientific Officer
Sold, plan not stated 2×
$7.25K 6,392 at 1.13
1.7%
4 Jan 2023
Johnston Lloyd P. Chief Operations Officer
Sold, plan not stated 2×
$7.25K 6,392 at 1.13
2.3%
5 Dec 2022
Brunn Carsten President and CEO
Sold, plan not stated
$6.01K 4,522 at 1.33
0.8%
28 Sep 2022
Brunn Carsten President and CEO
Sold, plan not stated
$4.47K 2,692 at 1.66
0.5%
2 Sep 2022
Brunn Carsten President and CEO
Sold, plan not stated
$8.81K 4,768 at 1.85
0.9%
13 Jun 2022
COX CARRIE SMITH Director
Bought
$149.80K 130,000 at 1.15
157%
Largest buy in 3 yrs
9 May 2022
BARABE TIMOTHY C Director
Bought
$38.72K 50,000 at 0.77
25.0%
+25% of stake
11 Apr 2022
SPRINGER TIMOTHY A Director · indirect
Bought
no price 6,681,600 shares
28.8%
+29% of stake
2 Mar 2022
Brunn Carsten President and CEO
Sold, plan not stated
$9.86K 5,443 at 1.81
1.0%
5 Jan 2022
Brunn Carsten President and CEO
Sold, plan not stated
$41.96K 13,597 at 3.09
2.6%
5 Jan 2022
Johnston Lloyd P. Chief Operations Officer
Sold, plan not stated
$10.54K 3,416 at 3.09
1.9%
5 Jan 2022
Kishimoto Takashi Kei Chief Scientific Officer
Sold, plan not stated
$10.54K 3,416 at 3.09
1.3%
5 Jan 2022
TRABER PETER G Chief Medical Officer
Sold, plan not stated
$9.96K 3,226 at 3.09
1.3%
15 Dec 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$631.10K 211,190 at 2.99
0.9%
13 Dec 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$43.49K 14,592 at 2.98
0.1%
10 Dec 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$175.44K 58,681 at 2.99
0.3%
10 Dec 2021
Brunn Carsten President and CEO
Sold, plan not stated
$51.36K 17,196 at 2.99
5.3%
10 Dec 2021
Kishimoto Takashi Kei Chief Scientific Officer
Sold, plan not stated
$13.05K 4,370 at 2.99
2.1%
10 Dec 2021
Johnston Lloyd P. Chief Operations Officer
Sold, plan not stated
$13.05K 4,370 at 2.99
3.9%
10 Dec 2021
TRABER PETER G Chief Medical Officer
Sold, plan not stated
$12.20K 4,083 at 2.99
2.4%
9 Dec 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$11.47M 3,748,000 at 3.06
19.6%
Largest buy in 3 yrs
3 Dec 2021
COX CARRIE SMITH Director
Bought
$50.66K 17,200 at 2.95
26.2%
First buy on file
2 Dec 2021
DeSilva Nishan M Director
Bought
$20.72K 7,000 at 2.96
opened
First buy on file
2 Dec 2021
Tan Kevin Chief Financial Officer
Bought
$15.13K 5,000 at 3.03
opened
First buy on file
2 Dec 2021
Brunn Carsten President and CEO
Sold, plan not stated
$14.06K 4,746 at 2.96
1.6%
13 Oct 2021
Brunn Carsten President and CEO
Sold, plan not stated
$67.22K 15,313 at 4.39
5.2%
13 Oct 2021
Johnston Lloyd P. Chief Operations Officer
Sold, plan not stated
$17.09K 3,892 at 4.39
3.8%
13 Oct 2021
Kishimoto Takashi Kei Chief Scientific Officer
Sold, plan not stated
$17.09K 3,892 at 4.39
2.0%
13 Oct 2021
TRABER PETER G Chief Medical Officer
Sold, plan not stated
$15.96K 3,636 at 4.39
2.3%
2 Sep 2021
Brunn Carsten President and CEO
Sold, plan not stated
$20.40K 4,523 at 4.51
1.9%
18 Aug 2021
BARABE TIMOTHY C Director
Bought
$36.00K 9,000 at 4.00
5.0%
2 Jun 2021
Brunn Carsten President and CEO
Sold, plan not stated
$21.04K 4,806 at 4.38
2.1%
26 May 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$3.71M 926,170 at 4.00
5.1%
26 May 2021
TRABER PETER G Chief Medical Officer
Bought
$79.85K 20,000 at 3.99
17.3%
25 May 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$1.36M 383,830 at 3.55
2.2%
25 May 2021
TRABER PETER G Chief Medical Officer
Bought
$17.40K 5,000 at 3.48
4.5%
24 May 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$1.99M 590,000 at 3.38
3.4%
24 May 2021
TRABER PETER G Chief Medical Officer
Bought
$41.50K 12,500 at 3.32
12.8%
21 May 2021
SPRINGER TIMOTHY A Director · indirect
Bought
$8.85M 2,773,479 at 3.19
19.2%
Largest buy in 3 yrs
26 Mar 2021
BARABE TIMOTHY C Director
Bought
$41.00K 10,000 at 4.10
5.8%
First buy on file
18 Mar 2021
TRABER PETER G Chief Medical Officer
Bought
$45.00K 10,000 at 4.50
11.4%
17 Mar 2021
Johnston Lloyd P. COO and SVP, R&D
Sold, plan not stated
$67.31K 15,128 at 4.45
14.7%
17 Mar 2021
TRABER PETER G Chief Medical Officer
Bought
$45.30K 10,000 at 4.53
12.8%
2 Mar 2021
Brunn Carsten President and CEO
Sold, plan not stated
$23.26K 5,461 at 4.26
2.5%
Showing 1–50 of 106. Page 1 of 3 Older →